[Event Report] The Third Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) (October 8, 2020)
date : 11/7/2020
Tags: AMR
Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the Third Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC).
Working groups (WG) were established under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.
At this third meeting of WG2, participants discussed the finalization of policy recommendations on pull incentives to encourage antimicrobial research and development. The meeting covered issues related to pull incentives from the perspective of what the most appropriate design would be given the nature of the Japanese healthcare system.
In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.
■Overview
Date and time: Thursday, October 8, 2020
Organizer: AMR Alliance Japan (Secretariat: HGPI), Nikkei Inc.
■Discussion
WG2 Members (alphabetical order by last name):
Yusuke Ariyoshi (Director, Healthcare Policy, Government Affairs Dept., Shionogi & Co., Ltd.)
Yoshiaki Gu (Chief, Information and Education Division, AMR Clinical Reference Center, National Center for Global Health and Medicine)
Yuri Miura (Senior Industry Policy Specialist, Public and Industrial Policy, Health Policy, MSD K.K.)
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Motoyuki Sugai (Director, Antimicrobial Resistance Research Center, National Institute of Infectious Diseases)
Yoshisaburo Takahashi (General Manager, Vaccine/Infections Dept., Meiji Seika Pharma Co., Ltd.)
Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
Akira Yuasa (Senior Manager, HTA/HEOR, Corporate Affairs, Health & Value, Pfizer Japan Inc.)
Moderator:
Yui Kohno (AMR Alliance Japan Secretariat/Associate, HGPI)
Secretariat (alphabetical order by last name):
Yuiko Kondo (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Matt McEnany (AMR Alliance Japan Secretariat/Senior Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Mio Wakasa (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)
January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
日本語
Top Research & Recommendations Posts
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Three Necessary Perspectives for Formulating the Basic Plan for the Promotion of Policies on Dementia: Creating a Society That is Inclusive for All People at All Times (April 1, 2024)
- [Policy Recommendations] Establishing an integrated care system for pain from the perspectives of people with lived experience (March 29, 2024)
Featured Posts
-
2024-04-02
[Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
-
2024-04-08
[Event Report] HGPI Participates in the Connecting Climate Minds Global Event (March 19-21, 2024)
-
2024-04-08
[Registration Open] The 124th HGPI Seminar “Reconsidering Infectious Disease Control Strategies Centering on Vaccination and Immunization – From the Experiences of the COVID-19 Pandemic and a Life Course Approach” (April 26, 2024)
-
2024-04-10
[Research Report] “International comparison of dementia policies, research study on information dissemination.” (April 10, 2024)
-
2024-04-11
[Research Paper] “Exploring the Potential of Industry-Academia-Civil Collaboration for Sustainability in the Healthcare Sector” Published in Journal Society for Environmental Economics and Policy Studies (March 31, 2024)